文献速递传染病防控与疫情报告免疫规划

印度5岁以下儿童细菌性脑膜炎医院哨点监测(PCV13引入前)

Hospital-based sentinel surveillance for bacterial meningitis in under-five children prior to the introduction of the PCV13 in India.
PubMed 文献 · Vaccine · 2021-05-29

主要病原为肺炎链球菌(74.2%),PCV13覆盖血清型占肺炎链球菌感染的72%,青霉素不敏感率57%,多重耐药43.7%。

要点

  • 5岁以下疑似脑膜炎患儿中实验室确诊细菌性脑膜炎比例为4.5%。
  • 肺炎链球菌占确诊病原的74.2%,PCV13血清型覆盖72%肺炎链球菌感染。
  • 青霉素不敏感率57%,多重耐药占43.7%,提示耐药监测重要性。

核心结论

  • 监测结果代表印度5岁以下儿童细菌性脑膜炎疾病负担,为将PCV纳入国家免疫规划提供依据。
  • 青霉素不敏感与多重耐药是重要观察结果,及时扩大PCV覆盖有望降低抗菌药物耐药负担。
  • PCV扩大后仍需持续监测以了解趋势变化。

研究设计与样本

  • 医院为基础的前瞻性哨点监测网络,覆盖印度11家医院。
  • 监测时间为2012年3月至2016年9月,纳入1至59月龄疑似细菌性脑膜炎患儿。
  • 脑脊液样本进行生化、培养、乳胶凝集和实时PCR检测,肺炎链球菌分离株行血清分型和药敏试验。

主要发现

  • 肺炎链球菌占74.2%,流感嗜血杆菌占22.2%,脑膜炎奈瑟菌占3.6%。
  • 确诊细菌性脑膜炎病例中58.1%为1至11月龄儿童。
  • 流感嗜血杆菌脑膜炎病死率高(12.3%)。
  • PCV13覆盖血清型引起72%的肺炎链球菌感染,常见血清型为14(18.3%)、6B(12.7%)和19F(9.9%)。

关键数值与推荐

  • 肺炎链球菌对青霉素不敏感率为57%。

临床怎么用

  • 监测数据可用于评估PCV引入前细菌性脑膜炎病原谱与耐药状况。
  • PCV13血清型覆盖多数肺炎链球菌感染,支持将PCV纳入国家免疫规划。
  • 青霉素不敏感和多重耐药高发提示需加强抗菌药物耐药监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: A hospital-based sentinel surveillance network for bacterial meningitis was established in India to estimate the burden of bacterial meningitis, and the proportion of major vaccine-preventable causative organisms. This report summarises the findings of the surveillance conducted between March 2012, and September 2016 in eleven hospitals. METHODS: We enrolled eligible children with bacterial meningitis in the age group of one to 59 months. CSF samples were collected and processed for biochemistry, culture, latex agglutination, and real-time PCR. Pneumococcal isolates were serotyped and tested for antimicrobial susceptibility. RESULTS: Among 12 941 enrolled suspected meningitis cases, 586 (4.5%) were laboratory confirmed. S. pneumoniae (74.2%) was the most commonly detected pathogen, followed by H. influenzae (22.2%), and N. meningitidis (3.6%). Overall 58.1% of confirmed bacterial meningitis cases were children aged between one, and 11 months. H. influenzae meningitis cases had a high (12.3%) case fatality rate. The serotypes covered in PCV13 caused 72% pneumococcal infections, and the most common serotypes were 14 (18.3%), 6B (12.7%) and 19F (9.9%). Non-susceptibility to penicillin was 57%. Forty-five (43.7%) isolates exhibited multidrug resistance, of which 37 were PCV13 serotype isolates. CONCLUSIONS: The results are representative of the burden of bacterial meningitis among under-five children in India. The findings were useful in rolling out PCV in the National Immunization Program. The non-susceptibility to penicillin and multidrug resistance was an important observation. Timely expansion of PCV across India will significantly reduce the burden of antimicrobial resistance. Continued surveillance is needed to understand the trend after PCV expansion in India.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Jayaraman Y, Veeraraghavan B, Girish Kumar CP, et al. Hospital-based sentinel surveillance for bacterial meningitis in under-five children prior to the introduction of the PCV13 in India. Vaccine. 2021. PMID: 34074545. doi:10.1016/j.vaccine.2021.05.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。